Headquartered in Cambridge, Massachusetts, Omega Therapeutics was founded by Flagship Pioneering in 2017 and is currently advancing a broad pipeline of programs that span regenerative medicine, multigenic diseases including immunology, oncology, and select monogenic diseases. With the guidance of founding scientific advisors Rudolf Jaenisch, PhD, and Richard Young, PhD, from MIT and the Whitehead Institute, Omega’s mission is to transform medicine in areas of high unmet need with well-defined and circumscribed patient populations . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge